T-cell immune responses and asymptomatic H5N1 influenza infection

Journal of Infectious Diseases

Volumn 205, Issue 1, 2012, Pages 4-6

  Epstein, Suzanne ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ASYMPTOMATIC INFECTION; CELLULAR IMMUNITY; CROSS REACTION; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; IMMUNOGENICITY; INFLUENZA A (H2N2); INFLUENZA A (H5N1); MASS SCREENING; MORBIDITY; MORTALITY; NONHUMAN; NOTE; PEPTIDE LIBRARY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INHIBITION; VIRUS SHEDDING;

ANIMALS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN;

EID: 84555189245     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir692     Document Type: Note

References (13)

1. Van KerkhoveMD, Mumford E,Mounts AW, et al. Highly pathogenic avian influenza (H5N1): pathways of exposure at the animalhuman interface, a systematic review. PLoS One 2011; 6:e14582.
2. Li FCK, Choi BCK, Sly T, Pak AWP. Finding the real case-fatality rate of H5N1 avian influenza. J Epidemiol Commun H 2008; 62:555-9. (Pubitemid 351731642)
3. Vong S, Ly S, Van Kerkhove MD, et al. Risk factors associated with subclinical human infection with avian influenza A (H5N1) virus-Cambodia, 2006. J Infect Dis 2009; 199:1744-52.
4. Cavailler P, Chu S, Ly S, et al. Seroprevalence of anti-H5 antibody in rural Cambodia, 2007. J Clin Virol 2010; 48:123-6.
5. Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Eng J Med 2006; 354: 1343-51.
6. Lee LY, Ha DLA, Simmons C, et al. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 2008; 118:3478-90.
7. Welsh RM, Selin LK. No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol 2002; 2:417-26. (Pubitemid 37328749)
8. Cornberg M, Clute SC, Watkin LB, et al. CD8 T cell cross-reactivity networks mediate heterologous immunity in human EBV and murine vaccinia virus infections. J Immunol 2010; 184:2825-38.
9. Buchy P, Vong S, Chu S, et al. Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus. PLoS One 2010; 5:e10864.
10. McMichael AJ, Dongworth DW, Gotch FM, Clark A, Potter CW. Declining T-cell immunity to influenza, 1977-82. Lancet 1983; 2:762-4. (Pubitemid 13003945)
11. Piacentini L, Fenizia C, Naddeo V, Clerici M. Not just sheer luck! Immune correlates of protection against HIV-1 infection. Vaccine 2008; 26:3002-7.
12. Kovacova A, Ruttkay-Nedecky G, Haverlik IK, Janecek S. Sequence similarities and evolutionary relationships of influenza virus A hemagglutinins. Virus Genes 2002; 24: 57-63. (Pubitemid 34229613)
13. Gras S, Kedzierski L, Valkenburg SA, et al. Cross-reactive CD81 T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc Natl Acad Sci USA 2010; 107:12599-604.